29370749|t|Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.
29370749|a|BACKGROUND: Alzheimer's disease (AD) is characterized by the deposition of amyloid-beta (Abeta) in brain parenchyma and cerebral blood vessels as cerebral amyloid angiopathy (CAA). Clusterin, a chaperon protein associated with Abeta aggregation, toxicity and transport through blood-brain barrier, may play a key role in the development of AD. Recently, clusterin peptide D-[113-122] was shown to mimic clusterin's function and exerted therapeutic effect in atherosclerosis. In this study, we investigated whether this clusterin peptide also affected (Abeta) deposition in AD transgenic mouse. RESULTS: Using a micropump, synthetic peptide 113-122 of clusterin protein (20 mug/200 mul) was infused into the lateral ventricle of 8-month 5 x FAD transgenic mouse model (Tg6799), for 2 weeks. Water-maze testing showed an improved cognitive function of the Tg6799 mice treated with clusterin. Immunocytochemistry and quantitative analysis revealed that intraventricular (icv) administration of clusterin peptide in Tg6799 mouse reduced Abeta plaques as well the severity of cerebral amyloid angiopathy. Enzyme-linked immunosorbent assay demonstrated a decreased in the soluble levels of Abeta (Abeta40 and Abeta42) in the brain. Western-blot revealed an increased level of LRP-2 after clusterin peptide treatment. CONCLUSION: These results suggest that icv infusion of clusterin peptide D-[113-122] offers a promising therapeutic approach to reduce Abeta deposition as well as CAA. The LRP2-mediated clearance system might be involved in the mechanism of these effects.
29370749	29	38	clusterin	Gene	12759
29370749	78	84	Tg6799	CellLine	CVCL:S723
29370749	94	113	Alzheimer's disease	Disease	MESH:D000544
29370749	127	146	Alzheimer's disease	Disease	MESH:D000544
29370749	148	150	AD	Disease	MESH:D000544
29370749	204	209	Abeta	Gene	11820
29370749	261	288	cerebral amyloid angiopathy	Disease	MESH:D016657
29370749	290	293	CAA	Disease	MESH:D016657
29370749	296	305	Clusterin	Gene	12759
29370749	342	347	Abeta	Gene	11820
29370749	361	369	toxicity	Disease	MESH:D064420
29370749	455	457	AD	Disease	MESH:D000544
29370749	469	478	clusterin	Gene	12759
29370749	518	527	clusterin	Gene	12759
29370749	573	588	atherosclerosis	Disease	MESH:D050197
29370749	634	643	clusterin	Gene	12759
29370749	667	672	Abeta	Gene	11820
29370749	688	690	AD	Disease	MESH:D000544
29370749	702	707	mouse	Species	10090
29370749	766	775	clusterin	Gene	12759
29370749	855	858	FAD	Disease	MESH:D000544
29370749	870	875	mouse	Species	10090
29370749	883	889	Tg6799	CellLine	CVCL:S723
29370749	969	975	Tg6799	CellLine	CVCL:S723
29370749	976	980	mice	Species	10090
29370749	994	1003	clusterin	Gene	12759
29370749	1106	1115	clusterin	Gene	12759
29370749	1127	1133	Tg6799	CellLine	CVCL:S723
29370749	1134	1139	mouse	Species	10090
29370749	1148	1153	Abeta	Gene	11820
29370749	1186	1213	cerebral amyloid angiopathy	Disease	MESH:D016657
29370749	1299	1304	Abeta	Gene	11820
29370749	1385	1390	LRP-2	Gene	14725
29370749	1397	1406	clusterin	Gene	12759
29370749	1481	1490	clusterin	Gene	12759
29370749	1561	1566	Abeta	Gene	11820
29370749	1589	1592	CAA	Disease	MESH:D016657
29370749	1598	1602	LRP2	Gene	14725
29370749	Association	11820	12759
29370749	Positive_Correlation	12759	14725
29370749	Association	MESH:D050197	12759
29370749	Association	MESH:D000544	12759
29370749	Negative_Correlation	MESH:D016657	12759

